Bizarre Patents
A banana protective device for storing and transporting a banana carefully.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7070802 | Pharmaceutical compositions for lipophilic drugs Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in a polar lipid, such as having a C6-C12 fatty a... | 07/04/2006 |
| RE39125 | Swallowing-assistive drink To provide a swallowing-assistive drink for medicines that improves swallowing various medicines, is convenient and substitutable with ordinary drinking water, and does not disturb the efficacy of medicines and a swallowing method. A swallowing-assistive drin... | 06/13/2006 |
| 7056530 | Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities A selfemulsifiable formulation comprising a lipophilic system consisting of a medium chain triglyceride of caprylic acid and capric acid, and of labrasol, wherein labrasol also serves as a surfactant, which is combined with other selected surfactants, like cremophor... | 06/06/2006 |
| 7033608 | “Burst-free” sustained release poly-(lactide/glycolide) microspheres Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1–100 days in an aqueous physiological environment. The microcapsules are comprised of a core o... | 04/25/2006 |
| 7022337 | Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect A fibrate self-emulsifying oral formulation with improved bioavailability when compared to commercially available formulations containing a therapeutically effective dose of fenofibrate, derivative of fenofibrate or mixtures thereof dissolved in a fibrate solubilize... | 04/04/2006 |
| 7022339 | Antidiabetic preparation for oral administration There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diab... | 04/04/2006 |
| 7014858 | Use methods of treating acne and telangiectasia A method of treating telangiectasia in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat telangiectasia, but has substantially no antibiotic activity. ... | 03/21/2006 |
| 7014869 | Rapid dehydration of proteins The present invention relates to protein-coated micro-crystals and their method of preparation. The protein-coated micro-crystals may find particular application in preparing enzymes for use as biocatalysts; preparation of therapeutic proteins for use in pharmaceuti... | 03/21/2006 |
| 7014862 | Chewable compositions containing a gel-forming extract of psyllium Oral compositions, suitable for chewing, comprising a gel-forming polysaccharide isolated from psyllium seed husks and an excipient that is fast dissolving in the oral cavity, provide good aesthetics and acceptable mouthfeel as perceived by the consumer. The oral co... | 03/21/2006 |
| 7008631 | Methods of simultaneously treating ocular rosacea and acne rosacea A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially ... | 03/07/2006 |
| 6994871 | Once a day antihistamine and decongestant formulation A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the im... | 02/07/2006 |
| 6991807 | Antibiotic composition Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and the at least two different antibiotics comprise at least one protein sy... | 01/31/2006 |
| 6986901 | Gastrointestinal compositions The invention relates to compositions and methods for treating and/or preventing lower gastrointestinal (GI) disorders in mammalian patients, more particularly for alleviating and/or preventing the lower GI symptoms associated with such disorders. ... | 01/17/2006 |
| 6982094 | Systems, methods and apparatuses for manufacturing dosage forms Systems, methods and apparatuses for manufacturing dosage forms, and to dosage forms made using such systems, methods and apparatuses are provided. Novel compression, thermal cycle molding, and thermal setting molding modules are disclosed. One or more of such modul... | 01/03/2006 |
| 6979467 | Microcapsules IV A microcapsule having a mean diameter of from about 0.1 to about 5 mm, a membrane and a matrix containing at least one active principle wherein the microcapsule is the product of the process comprising the steps of (a) forming an aqueous matrix by heating an aqueous... | 12/27/2005 |
| 6960349 | Pre-moistened wipe with lotion to improve dispensing A lotion suitable for use in a disposable wiping article is disclosed. The lotion can be used to wet pre-moistened wet wipes, and is particularly suited for use in pop-up dispensing systems of disposable wet wipes, such as baby wipes. The lotion provides for improve... | 11/01/2005 |
| 6955821 | Sustained release formulations of guaifenesin and additional drug ingredients The invention relates to a novel pharmaceutical sustained release formulation of guaifenesin and at least one additional drug ingredient. The formulation may comprise a hydrophilic polymer, preferably a hydroxypropyl methylcellulose, and a water-insoluble polymer, p... | 10/18/2005 |
| 6955820 | Coenzyme Q10 formulation and process methodology for softgel capsules manufacturing A formulation of Coenzyme Q10, beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a maximum of the Coenzyme Q10 is absorbed by the h... | 10/18/2005 |
| 6953593 | Sustained-release microencapsulated delivery system Disclosed is a process for producing sustained-release powders that is fast, efficient, and economical. The process involves melting an animal or vegetable oil with a melting point above 110 degrees F. in specially designed mixer through either the work energy input... | 10/11/2005 |
| 6946117 | Stabilized preparations for use in nebulizers Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a stabilized colloidal system which may comprise a fluorochemical component. In particularly preferred embodiments, t... | 09/20/2005 |
| 6942869 | Keratotic plug remover The invention relates to a keratotic plug remover comprising, as active ingredients, (A) a polymer having sulfonic or sulfate groups or having salts thereof and (B) a nonionic polymer, and a pack for pores of the skin containing said remover. The use of the pack for... | 09/13/2005 |
| 6942877 | Method for producing antibiotic composites A method for producing antibiotic composites is described, which is characterized in that a salt, which can be subjected to plastic deformation and which consists of at least one cationic component of a protonated antibiotics base from the groups of aminoglycoside a... | 09/13/2005 |
| 6936277 | Pharmaceutical excipient having improved compressibility A method of preparing an excipient composition includes forming an aqueous slurry containing a mixture of microcrystalline cellulose in the form of a wet cake and a surfactant, said surfactant being present in an amount from about 0.1% to about 0.5% by weight of the... | 08/30/2005 |
| 6936278 | Microparticles A process for producing microparticles, in which an aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active substance, an emulsion of starch droplets is formed in an outer phase... | 08/30/2005 |
| 6923953 | Hair treatment method The invention concerns a method for treating hair keratin fibers to provide them with new appropriate properties, comprising the following steps: reducing the sulphur bonds of hair keratin to generate only at the surface of the fibers at a depth less than 10 μm. re... | 08/02/2005 |
| 6916466 | Coupling of modified cyclodextrins to fibers Cyclodextrins and other ecapsulating oligosaccharides can be bound to fibrous and/or polysaccharidic carriers by ionic bonds. The ionic bonds can be produced by introducing cationic or anionic groups into the cyclodextrins, and where appropriate, by introducing oppo... | 07/12/2005 |
| 6908626 | Compositions having a combination of immediate release and controlled release characteristics Disclosed are compositions exhibiting a combination of immediate release and controlled release characteristics. The compositions comprise at least one poorly soluble active ingredient having a nanoparticulate particle size, at least one surface stabilizer adsorbed ... | 06/21/2005 |
| 6905707 | Controlled release arginine alpha ketoglutarate An oral formulation of arginine α-ketoglutarate is disclosed which formulation is comprised of arginine α-ketoglutarate and one or more excipient materials. A wide range of different controlled release formulations will be apparent to those skilled in the art upon... | 06/14/2005 |
| 6902746 | Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same The present invention provides oral pharmaceutical compositions for acetic acid class of non-steroidal anti-inflammatory drug (NSAID), particularly ketorolac. The pharmaceutical composition contains a core, a drug layer (which comprises the drug, a binder, and a dis... | 06/07/2005 |
| 6899899 | Rapidly disintegrable pharmaceutical composition The present invention relates to a pharmaceutical composition useful for rapid disintegration, which comprises a sparingly soluble medicament held on a gel-forming water-soluble polymer as a solid dispersion, wherein it contains a salt substance that comprises an al... | 05/31/2005 |
| 6890561 | Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one granulated isoflavone-enriched fraction and at least one carrier, di... | 05/10/2005 |
| 6887493 | Multi component controlled release system for oral care, food products, nutraceutical, and beverages The present invention relates to an improved controlled release system that can encapsulate different flavors, sensory markers, and active ingredients, or combinations of flavors, sensory markers and various active ingredients and release multiple active ingredients... | 05/03/2005 |
| 6878387 | Coated medicament forms with controlled active substance release The invention relates to a pharmaceutical preparation consisting of: (a) a core containing an active substance, optionally an excipient and common pharmaceutical additives in addition to the salt of an inorganic acid whose proportion in the weight of the core ranges... | 04/12/2005 |
| 6875443 | Encapsulated long chain alcohols The present invention is directed to the encapsulation of long chain alcohols, C20-C36, in various materials including polymers and waxes. Through the proper selection of the polymer the encapsulated long chain alcohol can be advantageously add... | 04/05/2005 |
| 6875449 | Crystal structure A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals, especially lactose, lactose monohydrate, fluticasone propionate, salmeterol ... | 04/05/2005 |
| 6869611 | Composition and method of effecting superficial chemical skin peels A method for effecting a superficial chemical skin peel is provided wherein a concentrated solution of salicylic acid in a dermatologically acceptable solvent is applied to be treated. The concentrated salicylic acid solution contains at least 15 wt % salicylic acid... | 03/22/2005 |
| 6869614 | Chewing gum containing calcium A gum, lollipop and lozenge having at least two separate components, with at least one of such components containing amounts of herbal, medicinal and/or mineral elements or combinations thereof. ... | 03/22/2005 |
| 6866865 | Dosage forms and methods for oral delivery of progesterone Oral progesterone unit dosage forms comprising micronized progesterone and a solid polymeric carrier are provided. The dosage forms, upon oral administration, provide a therapeutically effective blood level of progesterone to a subject. The therapeutically effective... | 03/15/2005 |
| 6863899 | Composite shaped bodies and methods for their production and use Shaped, composite bodies are provided. One portion of the shaped bodies comprises an RPR-derived porous inorganic material, preferably a calcium phosphate. Another portion of the composite bodies is a different solid material, preferably metal, glass, ceramic or pol... | 03/08/2005 |
| 6863901 | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration New pharmaceutical compositions in unit dosage form are disclosed for both intraoral and oral administration to a patient, said unit dosage form configured to be placed intraorally of said patient, which comprises: (a) as a first p... | 03/08/2005 |
